Your browser doesn't support javascript.
loading
Disease-modifying drugs for multiple sclerosis and subsequent health service use.
Ng, Huah Shin; Zhu, Feng; Kingwell, Elaine; Zhao, Yinshan; Yao, Shenzhen; Ekuma, Okechukwu; Svenson, Lawrence W; Evans, Charity; Fisk, John D; Marrie, Ruth Ann; Tremlett, Helen.
Affiliation
  • Ng HS; Department of Medicine, Division of Neurology and the Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.
  • Zhu F; Department of Medicine, Division of Neurology and the Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.
  • Kingwell E; Department of Medicine, Division of Neurology and the Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada/Research Department of Primary Care & Population Health, University College London, London, UK.
  • Zhao Y; Department of Medicine, Division of Neurology and the Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.
  • Yao S; College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada/Health Quality Council, Saskatoon, SK, Canada.
  • Ekuma O; Department of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
  • Svenson LW; Alberta Health, Edmonton, AB, Canada/Division of Preventive Medicine & School of Public Health, University of Alberta, Edmonton, AB, Canada/Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Evans C; College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada.
  • Fisk JD; Nova Scotia Health Authority and the Departments of Psychiatry, Psychology and Neuroscience, and Medicine, Dalhousie University, Halifax, NS, Canada.
  • Marrie RA; Departments of Internal Medicine and Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
  • Tremlett H; Department of Medicine, Division of Neurology and the Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada/Division of Neurology, Department of Medicine, Faculty of Medicine, UBC Hospital, Vancouver, BC, Canada.
Mult Scler ; 28(4): 583-596, 2022 Apr.
Article in En | MEDLINE | ID: mdl-34949130

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis Type of study: Prognostic_studies Limits: Aged / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2022 Document type: Article Affiliation country: Canada Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis Type of study: Prognostic_studies Limits: Aged / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2022 Document type: Article Affiliation country: Canada Country of publication: United kingdom